Brief: Octagon Capital Advisors Lp Reports 9.7% Passive Stake In Allovir Inc As Of Sept 30-SEC Filing
11/10/2024 21:23
Allovir Inc ALVR.O :
* OCTAGON CAPITAL ADVISORS LP REPORTS 9.7% PASSIVE STAKE IN
ALLOVIR INC AS OF SEPT 30-SEC FILING
Source text for Eikon: ID:n0001214659-24-017476
Further company coverage: ALVR.O
Recent news on Kalaris Therapeutics
See all newsKalaris Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Kalaris Therapeutics Q2 net loss narrows on lower administrative costs
Kalaris Therapeutics Inc expected to post a loss of 49 cents a share - Earnings Preview
Kalaris Therapeutics posts smaller-than-expected Q1 net loss
Brief: Kalaris Therapeutics Inc Q1 Operating Income USD -11.833 Million